Project Grant R34MH141488
- The National Institute of Mental Health awarded Pennsylvania State University (Penn State Milton S. Hershey Medical Center) $704,700 on May 22, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and pilot a transdiagnostic sleep and circadian intervention adapted for autistic adolescents and young adults ages 12–25. The project adapts TRANS-C (Transdiagnostic Intervention for Sleep and Circadian Dysfunction), an existing evidence-based sleep intervention, to address...
- The National Institute of Mental Health awarded Cincinnati Children's Hospital Medical Center $820,196 on March 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct observational and mechanistic research on circadian misalignment in adolescents with attention-deficit/hyperactivity disorder (ADHD). The project investigates how the timing mismatch between adolescents' internal circadian phase and early school start times affects attention and functional outcomes in...
- The National Institute of Mental Health awarded Massachusetts General Hospital $197,578 on June 1, 2026, under the Mental Health Research Grants program (CFDA 93.242, K23MH144215) to investigate sleep and circadian timing irregularities as short-term risk factors for adolescent suicide through intensive longitudinal study. The research recruits 100 adolescents hospitalized for suicidal thoughts and behaviors, continuously monitoring objective sleep metrics via wrist actigraphy and collecting...
- The National Institute of Mental Health awarded Emma Pendleton Bradley Hospital $398,669 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the relationship between sleep disruption and psychosis-spectrum symptoms in adolescents aged 14–17 years. The research addresses three mechanistic gaps in the literature: the absence of dense sampling across days to measure temporal fluctuations between psychosis-spectrum symptoms and sleep in youth; reliance on...
- The National Institute of Mental Health awarded $725,816 to the University of Oregon on May 1, 2026, to optimize and evaluate a Sleep-Enhanced Family Media Plan for early adolescents' sleep problems under the Mental Health Research Grants program (CFDA 93.242). The project, titled "Enhancing a Technology and Digital Media Use Intervention to Address Youth Sleep Problems," addresses the gap that over half of adolescents obtain insufficient sleep on school nights while technology and...
- The National Institute of Mental Health awarded The Leland Stanford Junior University $977,740 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct research examining sleep as a predictor of depression onset in adolescence. The research applies a deep-learning framework to two large public longitudinal datasets—the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA; N=624) and the Adolescent Brain Cognitive Development Cohort...
- The National Institute of Mental Health awarded Boston Children's Hospital $153,560 on January 7, 2027, under the Mental Health Research Grants program (CFDA 93.242) to conduct a postdoctoral fellowship examining the relationship between sleep physiology, myelin content, and depressive symptoms in young people ages 9–26 years. The research leverages data from two ongoing R01 studies to investigate two specific aims: understanding the relationship between sleep EEG signatures (spindles and slow...
- The National Institute of Mental Health awarded The General Hospital Corporation (Massachusetts General Hospital) $765,876 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct advanced neuroimaging research on subcortical brain dynamics during human sleep. The recipient will use high-resolution 7-Tesla functional magnetic resonance imaging and simultaneous electroencephalography with a novel ultra-high-field compatible net to map circuit activity in the...
- The National Institute of Mental Health awarded Cincinnati Children's Hospital Medical Center $802,494 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal study of cognitive disengagement syndrome as a transdiagnostic predictor of psychopathology across adolescence. The funded research extends an ongoing longitudinal study tracking 341 community-recruited adolescents (ages 10–12 years at baseline, enriched for cognitive disengagement syndrome...
- The National Institute of Mental Health awarded $819,721 to the Regents of the University of California, San Francisco on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal investigation of whether a perinatal insomnia intervention improves offspring social-emotional development. The award funds the Growing Offspring Wellness Study (GROW Study), which will follow mother-offspring dyads from the existing NIMH-funded PRISM Study as they age from...
The National Institute of Mental Health awarded The Rand Corporation $792,687 on August 17, 2026, under the Mental Health Research Grants program (CFDA 93.242) to adapt and pilot test a transdiagnostic sleep and circadian intervention for adolescents aged 14–17 exposed to early life adversity and experiencing sleep disturbances. The project, titled "Improving Sleep and Emotional Well-Being in Adolescents with Early Life Adversity: A Transdiagnostic Sleep and Circadian Intervention," will adapt the TRANS-C intervention to be trauma-informed and meet the needs of child welfare-involved youth in collaboration with the Olive View Clinic, a pediatric clinic serving adolescents with early life adversity. Aim 1 involves adapting the intervention through focus groups with adolescents, parents, and behavioral health providers, and usability testing among five early life adversity-exposed adolescents with sleep disturbances. Aim 2 will conduct a pilot randomized controlled trial comparing the adapted TRANS-C to a delayed treatment control among 60 adolescents. Primary outcomes include sleep duration, social jetlag, and depression; secondary outcomes include sleep quality, sleep efficiency, sleep timing, daytime alertness, anxiety, PTSD symptoms, and daily affect. The period of performance runs through July 31, 2029. Work is performed in California.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $792.7k | 8/19/26 |